Back to Agenda
Session 9 Track 2: Automation Technologies in Medical Writing
Session Chair(s)
Ruggero Galici, PhD
Director, Nonclinical and Clinical Pharmacology Writing
Alexion Pharmaceuticals, AstraZeneca Rare Disease, United States
Automation technologies, especially when combined with artificial intelligence, are disrupting many sectors including the healthcare. This session will explore challenges and opportunities of automation technologies in medical writing. Few examples of how companies and the FDA are using or plan to use automation technologies to improve efficiencies will be discussed.
Learning Objective : At the conclusion of this session, participants should be able to:- Identify potential automation technologies in medical writing
- Recognize challenges and opportunities when implementing automation technologies in medical writing
Speaker(s)
Automation and AI in Medical Writing: Pie in the Sky or a Paradigm Shift?
Sian Ratcliffe, PhD
Pfizer Inc, United States
Vice President, Head of Medical Writing
AI in the Medical Writing Landscape – Tales from a Pilot Project
Julia Forjanic-Klapproth, PhD
Trilogy Writing & Consulting, Germany
Senior Partner/President
Digitizing Decision Documentation at the FDA – Are We There Yet?
Eileen E. Navarro Almario, MD, MS, FACP
FDA, United States
Lead Physician
Have an account?